Tue.Jan 11, 2022

article thumbnail

Pfizer, Moderna are prepping new vaccines for Omicron

pharmaphorum

With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both Pfizer and Moderna have announced plans to develop new versions of their mRNA-based shots that are tailored to the new variant. Pfizer has said that a COVID-19 jab specifically targeting Omicron, as well as other existing variants, will begin human trials later this month and could be available as early as March.

Vaccines 126
article thumbnail

JPM 2022: CVS Health boosts 2021 guidance on back of stronger than expected retail performance in Q4

Fierce Healthcare

JPM 2022: CVS Health boosts 2021 guidance on back of stronger than expected retail performance in Q4. pminemyer. Tue, 01/11/2022 - 09:06.

121
121
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Life sciences predictions for 2022

pharmaphorum

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.

96
article thumbnail

CMS proposes narrowly covering controversial Alzheimer's drug Aduhelm for patients in clinical trials

Fierce Healthcare

CMS proposes narrowly covering controversial Alzheimer's drug Aduhelm for patients in clinical trials. rking. Tue, 01/11/2022 - 16:26.

115
115
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

BMS cuts $3.15bn deal with Century for cancer cell therapies

pharmaphorum

Bristol-Myers Squibb chief executive Giovanni Caforio has promised to invest in the company’s pipeline at the virtual JP Morgan Healthcare Conference, and demonstrated that commitment by licensing up to four cancer cell therapy candidates from Century Therapeutics. BMS is paying $150 million upfront in cash and equity to kick off the alliance with another $3 billion in additional payments that will be forthcoming if the projects advance as hoped.

91
article thumbnail

JPM22, Day 2: Primary care startup Aledade inks tuck-in acquisition and more

Fierce Healthcare

JPM22, Day 2: Primary care startup Aledade inks tuck-in acquisition and more. hlandi. Tue, 01/11/2022 - 07:46.

126
126

More Trending

article thumbnail

Labor Department demands insurers to stop flouting ACA's birth control rules

Fierce Healthcare

Labor Department demands insurers to stop flouting ACA's birth control rules. rking. Tue, 01/11/2022 - 12:06.

Insurance 126
article thumbnail

Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda

pharmaphorum

Merck & Co’s Keytruda is the undisputed market leader in immunotherapy for non-small cell lung cancer (NSCLC), but was leapfrogged by Roche’s Tecentriq in the early-stage, adjuvant treatment setting. Now, it’s hoping to fight back with new phase 3 data. In the KEYNOTE-091 trial, Keytruda (pembrolizumab) significantly improved disease-free survival compared to placebo when given after surgery to remove NSCLC tumours, regardless of their level of PD-L1 expression, meeting one

article thumbnail

JPM 2022: CMS, BCBS leaders share strategies to tackle health inequities long-term

Fierce Healthcare

JPM 2022: CMS, BCBS leaders share strategies to tackle health inequities long-term. agliadkovskaya. Tue, 01/11/2022 - 19:42.

105
105
article thumbnail

Employee Spotlight: Stephanie Everard Pharmacist

indispensable health

Indispensable Health Employee Interview. “ My Name is Stephanie Everard and I am a Pharmacist Team Member with Indispensable Health ” — Stephanie Everard, PharmD. Stephanie, when did you become interested in pharmacy? I became interested in pharmacy in high school. I spent time working in a community pharmacy and a compounding pharmacy.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

JPM 2022: Bon Secours Mercy Health worries rising labor expenses could stymie push into diversified growth

Fierce Healthcare

JPM 2022: Bon Secours Mercy Health worries rising labor expenses could stymie push into diversified growth. rking. Tue, 01/11/2022 - 09:32.

98
article thumbnail

Pharma USA 2022 – Where Pharma Self-Disrupts

Pharma Marketing Network

Pharma USA 2022 is North America’s leading commercial pharma event. Here is where we will witness the moment where pharma will learn to self-disrupt. The opportunity to redefine what an industry means doesn’t come around often. For pharma, that moment is now. It’s time to lead the overhaul of our broken healthcare system to one that is fit-for-purpose.

52
article thumbnail

Providence Hoag to end affiliation with Providence by Jan. 31

Fierce Healthcare

Providence Hoag to end affiliation with Providence by Jan. 31. dmuoio. Tue, 01/11/2022 - 14:21.

110
110
article thumbnail

Healthware Group appoints Jonah Comstock as Editor-in-Chief

pharmaphorum

Healthware has appointed Jonah Comstock as editor-in-chief to further growth and expansion of the Group’s Media and Community business which aims at fostering the dialogue and the connections among the digital health community helping industry, policymakers, and physicians to embrace the digital transformation of health. With a strong background in journalism, specialising in health tech and digital health, Jonah will have editorial oversight of Healthware media and community assets, including p

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Medicare advisor firm Chapter scores $42M in latest funding round

Fierce Healthcare

Medicare advisor firm Chapter scores $42M in latest funding round. agliadkovskaya. Tue, 01/11/2022 - 10:10.

104
104
article thumbnail

Oxford joins consortium to advance quantum drug discovery

Pharma Times

The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.

55
article thumbnail

JPM 2022: Tenet Healthcare touts restructure progress, swelling ambulatory surgical center business

Fierce Healthcare

JPM 2022: Tenet Healthcare touts restructure progress, swelling ambulatory surgical center business. dmuoio. Tue, 01/11/2022 - 16:33.

52
article thumbnail

European Commission approves cystic fibrosis treatment for six to 11-year-olds

Pharma Times

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK currently diagnosed with the disease.

49
article thumbnail

JPM 2022: Omicron wave bumps UHS' hopes for labor cost recovery back at least 3 months

Fierce Healthcare

JPM 2022: Omicron wave bumps UHS' hopes for labor cost recovery back at least 3 months. dmuoio. Tue, 01/11/2022 - 10:10.

52
article thumbnail

What HCPs think about mandatory vaccination

pharmaphorum

What HCPs think about mandatory vaccination. The practice of making vaccinations mandatory within a population has always been controversial. Historically, the first example of this was during the smallpox epidemic in the 1800s , when some European countries attempted to make vaccination against the disease compulsory. While it is hard to argue against the overall aim of disease eradication, there are many ethical, medical, and social issues intertwined with the idea of enforcing vaccination.

article thumbnail

JPM 2022: Tullman's Transcarent confirms $1.62B valuation with $200M series C, looks to expand into in-home care

Fierce Healthcare

JPM 2022: Tullman's Transcarent confirms $1.62B valuation with $200M series C, looks to expand into in-home care. rtorrence. Tue, 01/11/2022 - 14:36.

40
article thumbnail

JPM 2022: CEO Cordani offers a look at Cigna's primary care strategy

Fierce Healthcare

JPM 2022: CEO Cordani offers a look at Cigna's primary care strategy. pminemyer. Tue, 01/11/2022 - 12:45.

45